Panelists discuss how the pathophysiology of pulmonary arterial hypertension involves complex mechanisms across multiple genetic and treatment pathways, with over 20 identified genes and four major ...

Panelists discuss how prostacyclin pathway treatments remain important but challenging due to significant side effects and delivery complexity, with sotatercept potentially reducing reliance on ...

This article will focus on pulmonary hypertension, or, more specifically, pulmonary arterial hypertension (PAH), and will review clinical findings associated with the disease as well as diagnostic ...

Direct anti-VEGF angiogenic agents were a strong risk factor for high-grade hypertension, and multikinase inhibitors for high-grade proteinuria. Vascular endothelial growth factor signaling pathway ...

Oxidative stress can occur when our cells are exposed to harmful molecules called “reactive oxygen species” over time. These reactive oxygen species can damage cells and are found in important disease ...

Ferrer is using Pulmonary Hypertension Awareness Month to sound the alarm about the shortcomings of the current pathways for diagnosing and treating the blood pressure condition. The Spanish company ...

Formal written minutes from the U.S. FDA confirms no major concerns identified for the planned Phase 3 PANDA study of ...

As healthcare becomes more entrenched in the digital revolution, the need for an approved set of protocols for care delivery — clinical pathways — is becoming increasingly critical. Clinical pathways, ...

The epidemiology of hypertension in India has undergone a malignant shift, moving from a disease of the elderly to a ...

Preliminary results from a pooled analysis of clinical trial data evaluating the long-term safety and favorable benefit-risk profile of WINREVAIR™ to be featured as a late-breaking presentation RAHWAY ...